Differentiating Left Ventricular Remodeling in Aortic Stenosis From Systemic Hypertension.


Journal

Circulation. Cardiovascular imaging
ISSN: 1942-0080
Titre abrégé: Circ Cardiovasc Imaging
Pays: United States
ID NLM: 101479935

Informations de publication

Date de publication:
Aug 2024
Historique:
medline: 20 8 2024
pubmed: 20 8 2024
entrez: 20 8 2024
Statut: ppublish

Résumé

Left ventricular (LV) hypertrophy occurs in both aortic stenosis (AS) and systemic hypertension (HTN) in response to wall stress. However, differentiation of hypertrophy due to these 2 etiologies is lacking. The aim was to study the 3-dimensional geometric remodeling pattern in severe AS pre- and postsurgical aortic valve replacement and to compare with HTN and healthy controls. Ninety-one subjects (36 severe AS, 19 HTN, and 36 healthy controls) underwent cine cardiac magnetic resonance. Cardiac magnetic resonance was repeated 8 months post-aortic valve replacement (n=18). Principal component analysis was performed on the 3-dimensional meshes reconstructed from 109 cardiac magnetic resonance scans of 91 subjects at end-diastole. Principal component analysis modes were compared across experimental groups together with conventional metrics of shape, strain, and scar. A unique AS signature was identified by wall thickness linked to a LV left-right axis shift and a decrease in short-axis eccentricity. HTN was uniquely linked to increased septal thickness. Combining these 3 features had good discriminative ability between AS and HTN (area under the curve, 0.792). The LV left-right axis shift was not reversible post-aortic valve replacement, did not associate with strain, age, or sex, and was predictive of postoperative LV mass regression (R Unique remodeling signatures might differentiate the etiology of LV hypertrophy. Preliminary findings suggest that LV axis shift is characteristic in AS, is not reversible post-aortic valve replacement, predicts mass regression, and may be interpreted to be an adaptive mechanism.

Sections du résumé

BACKGROUND UNASSIGNED
Left ventricular (LV) hypertrophy occurs in both aortic stenosis (AS) and systemic hypertension (HTN) in response to wall stress. However, differentiation of hypertrophy due to these 2 etiologies is lacking. The aim was to study the 3-dimensional geometric remodeling pattern in severe AS pre- and postsurgical aortic valve replacement and to compare with HTN and healthy controls.
METHODS UNASSIGNED
Ninety-one subjects (36 severe AS, 19 HTN, and 36 healthy controls) underwent cine cardiac magnetic resonance. Cardiac magnetic resonance was repeated 8 months post-aortic valve replacement (n=18). Principal component analysis was performed on the 3-dimensional meshes reconstructed from 109 cardiac magnetic resonance scans of 91 subjects at end-diastole. Principal component analysis modes were compared across experimental groups together with conventional metrics of shape, strain, and scar.
RESULTS UNASSIGNED
A unique AS signature was identified by wall thickness linked to a LV left-right axis shift and a decrease in short-axis eccentricity. HTN was uniquely linked to increased septal thickness. Combining these 3 features had good discriminative ability between AS and HTN (area under the curve, 0.792). The LV left-right axis shift was not reversible post-aortic valve replacement, did not associate with strain, age, or sex, and was predictive of postoperative LV mass regression (R
CONCLUSIONS UNASSIGNED
Unique remodeling signatures might differentiate the etiology of LV hypertrophy. Preliminary findings suggest that LV axis shift is characteristic in AS, is not reversible post-aortic valve replacement, predicts mass regression, and may be interpreted to be an adaptive mechanism.

Identifiants

pubmed: 39163368
doi: 10.1161/CIRCIMAGING.123.016489
doi:

Types de publication

Journal Article Comparative Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e016489

Déclaration de conflit d'intérêts

None.

Auteurs

Masliza Mahmod (M)

University of Oxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, Radcliffe Department of Medicine (M.M., K.C., R.A., B.R., M.R., J.M.F., S.D., S.G.M., S.N.), University of Oxford, United Kingdom.

Kenneth Chan (K)

University of Oxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, Radcliffe Department of Medicine (M.M., K.C., R.A., B.R., M.R., J.M.F., S.D., S.G.M., S.N.), University of Oxford, United Kingdom.

Joao F Fernandes (JF)

Department of Biomedical Engineering (J.F.F., H.-F.R.L., P.L.), King's College of London, United Kingdom.

Rina Ariga (R)

University of Oxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, Radcliffe Department of Medicine (M.M., K.C., R.A., B.R., M.R., J.M.F., S.D., S.G.M., S.N.), University of Oxford, United Kingdom.

Betty Raman (B)

University of Oxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, Radcliffe Department of Medicine (M.M., K.C., R.A., B.R., M.R., J.M.F., S.D., S.G.M., S.N.), University of Oxford, United Kingdom.

Ernesto Zacur (E)

Department of Biomedical Engineering (E.Z.), University of Oxford, United Kingdom.

Ho-Fon Royce Law (HR)

Department of Biomedical Engineering (J.F.F., H.-F.R.L., P.L.), King's College of London, United Kingdom.

Jane M Francis (JM)

University of Oxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, Radcliffe Department of Medicine (M.M., K.C., R.A., B.R., M.R., J.M.F., S.D., S.G.M., S.N.), University of Oxford, United Kingdom.

Sairia Dass (S)

University of Oxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, Radcliffe Department of Medicine (M.M., K.C., R.A., B.R., M.R., J.M.F., S.D., S.G.M., S.N.), University of Oxford, United Kingdom.

Kevin O'Gallagher (K)

Department Cardiovascular Medicine (K.O.G.), King's College of London, United Kingdom.

Saul G Myerson (SG)

University of Oxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, Radcliffe Department of Medicine (M.M., K.C., R.A., B.R., M.R., J.M.F., S.D., S.G.M., S.N.), University of Oxford, United Kingdom.

Theodoros D Karamitsos (TD)

1st Department of Cardiology, Aristotle University, Thessaloniki, Greece (T.D.K.).

Stefan Neubauer (S)

University of Oxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, Radcliffe Department of Medicine (M.M., K.C., R.A., B.R., M.R., J.M.F., S.D., S.G.M., S.N.), University of Oxford, United Kingdom.

Pablo Lamata (P)

Department of Biomedical Engineering (J.F.F., H.-F.R.L., P.L.), King's College of London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH